Supravent

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSupravent
Drug Alias Nameadenosine (sublingual)MEDR-240
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine receptor agonists
TargetsAdenosine receptor
Therapy Area/IndicationsArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMediolanum Farmaceutici Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMediolanum Farmaceutici Spa
Active IndicationsN/A
Inactive IndicationsArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksN/A